nach oben

Cancer Chemotherapy and Pharmacology

Erschienen in:

27.09.2023 | Original Article

Sodium orthovanadate exhibits anti-angiogenic, antiapoptotic and blood glucose-lowering effect on colon cancer associated with diabetes

verfasst von: Kruti Patel, Vivek Bora, Bhoomika Patel

Erschienen in: Cancer Chemotherapy and Pharmacology | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

The presence of type 2 diabetes mellitus increases the risk of developing the colon cancer. The main objective of this study was to determine the role of sodium orthovanadate (SOV) in colon cancer associated with diabetes mellitus by targeting the competitive inhibition of PTP1B.

Methods

For in vivo study, high fat diet with low dose streptozotocin model was used for inducing the diabetes mellitus. Colon cancer was induced by injecting 1,2-dimethylhydrazine (25 mg/kg, sc) twice a week. TNM staging and immunohistochemistry (IHC) was carried out for colon cancer tissues. In vitro studies like MTT assay, clonogenic assay, rhodamine-123 dye assay and annexin V-FITC assay using flow cytometry were performed on HCT-116 cell line. CAM assay was performed to examine the anti-angiogenic effect of the drug.

Results

Sodium orthovanadate reduces the blood glucose level and tumor parameters in the animals. In vitro studies revealed that SOV decreased cell proliferation dose dependently. In addition, SOV induced apoptosis as depicted from rhodamine-123 dye assay and annexin V-FITC assay using flow cytometry as well as p53 IHC staining. SOV showed reduced angiogenesis effect on eggs which was depicted from CAM assay and also from CD34 and E-cadherin IHC staining.

Conclusions

Our data suggest that SOV exhibits protective role in colon cancer associated with diabetes mellitus. SOV exhibits anti-proliferative, anti-angiogenic and apoptotic inducing effects hence can be considered for therapeutic switching in diabetic colon cancer.

Berridge MV, Herst PM, Tan AS (2005) Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev 11(SUPPL):127–152. https://doi.org/10.1016/S1387-2656(05)11004-7CrossRefPubMed

Bild AH et al (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439(7074):353–357. https://doi.org/10.1038/nature04296CrossRefPubMed

Bottinger E (2007) Foundations, promises and uncertainties of personalized medicine address correspondence to. Mt Sinai J Med 1:15–21. https://doi.org/10.1002/msj.20005CrossRef

Chen PJ et al (2015) Protein tyrosine phosphatase 1B (PTP1B): a key regulator and therapeutic target in liver diseases. Toxicology 337:10–20. https://doi.org/10.1016/j.tox.2015.08.006CrossRefPubMed

Delwar ZM et al (2012) Menadione: sodium orthovanadate combination eliminates and inhibits migration of detached cancer cells. ISRN Pharmacol 2012:1–10. https://doi.org/10.5402/2012/307102CrossRef

Devasagayam TPA, Boloor KK, Ramasarma T (2003) Methods for estimating lipid peroxidation: an analysis of merits and demerits. Indian J Biochem Biophys 40(5):300–308PubMed

Dorsey BM, McLauchlan CC, Jones MA (2018) Evidence that speciation of oxovanadium complexes does not solely account for inhibition of leishmania acid phosphatases. Front Chem. https://doi.org/10.3389/fchem.2018.00109CrossRefPubMedPubMedCentral

Elchebly M et al (1999) Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283(5407):1544–1548. https://doi.org/10.1126/science.283.5407.1544CrossRefPubMed

Franken NAP et al (2006) Clonogenic assay of cells in vitro. Nat Protoc 1(5):2315–2319. https://doi.org/10.1038/nprot.2006.339CrossRefPubMed

10.

Giouleme O, Diamantidis MD, Katsaros MG (2011) Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms. World J Gastroenterol 17(4):444–448. https://doi.org/10.3748/wjg.v17.i4.444CrossRefPubMedPubMedCentral

11.

Goldstein BJ et al (2000) Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the GRB2 adaptor protein. J Biol Chem 275(6):4283–4289. https://doi.org/10.1074/jbc.275.6.4283CrossRefPubMed

12.

Gonçalves AP et al (2011) Orthovanadate-induced cell death in RET/PTC1-harboring cancer cells involves the activation of caspases and altered signaling through PI3K/Akt/mTOR. Life Sci 89(11–12):371–377. https://doi.org/10.1016/j.lfs.2011.07.004CrossRefPubMed

13.

Gupta BL, Preet A, Baquer NZ (2004) Protective effects of sodium orthovanadate in diabetic reticulocytes and ageing red blood cells of Wistar rats. J Biosci 29(1):73–79. https://doi.org/10.1007/BF02702564CrossRefPubMed

14.

Hanas R, John G (2010) 2010 Consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Diabetes Care 33(8):1903–1904. https://doi.org/10.2337/dc10-0953CrossRefPubMedPubMedCentral

15.

Homandberg GA (2009) The protein protocols handbook, 3rd edn. Humana Press, Totowa, p 77. https://doi.org/10.1007/978-1-59745-198-7 (8(1))CrossRef

16.

Inokuma T et al (2009) Oxidative stress and tumor progression in colorectal cancer. Hepatogastroenterology 56(90):343–347PubMed

17.

Izumi H et al (2015) Favorable effect of the combination of vinorelbine and dihydropyrimidine dehydrogenase-inhibitory fluoropyrimidine in EGFR-mutated lung adenocarcinoma: retrospective and in vitro studies. Int J Oncol 46(3):989–998. https://doi.org/10.3892/ijo.2015.2815CrossRefPubMedPubMedCentral

18.

Jorand R et al (2016) Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer. Mol Biol Cell 27(22):3659–3672. https://doi.org/10.1091/mbc.E16-06-0427CrossRefPubMedPubMedCentral

19.

Kalmer M et al (2022) Clonogenic assays improve determination of variant allele frequency of driver mutations in myeloproliferative neoplasms. Ann Hematol 101(12):2655–2663. https://doi.org/10.1007/S00277-022-05000-9CrossRefPubMedPubMedCentral

20.

Kandoth C et al (2013) Mutational landscape and significance across 12 major cancer types. Nature 502(7471):333–339. https://doi.org/10.1038/nature12634CrossRefPubMedPubMedCentral

21.

Khalil AA, Jameson MJ (2017) Sodium orthovanadate inhibits proliferation and triggers apoptosis in oral squamous cell carcinoma in vitro. Biochem Mosc 82(2):149–155. https://doi.org/10.1134/S0006297917020067CrossRef

22.

Kim SA et al (2016) Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis. Br J Cancer 114(2):199–206. https://doi.org/10.1038/bjc.2015.347CrossRefPubMedPubMedCentral

23.

Kowalski S et al (2017) Selective cytotoxicity of vanadium complexes on human pancreatic ductal adenocarcinoma cell line by inducing necroptosis, apoptosis and mitotic catastrophe process. Oncotarget 8(36):60324–60341. https://doi.org/10.18632/oncotarget.19454CrossRefPubMedPubMedCentral

24.

Krishnan N et al (2015) PTP1B inhibition suggests a therapeutic strategy for Rett syndrome Find the latest version: PTP1B inhibition suggests a therapeutic strategy for Rett syndrome. J Clin Investig 125(8):3163–3177. https://doi.org/10.1172/JCI80323.focusingCrossRefPubMedPubMedCentral

25.

Kue CS et al (2014) Chick embryo chorioallantoic membrane (CAM): an alternative predictive model in acute toxicological studies for anti-cancer drugs. Exp Anim 64(2):129–138. https://doi.org/10.1538/expanim.14-0059CrossRef

26.

Kumar P et al (2015) Sodium orthovanadate and trigonella foenum graecum prevents neuronal parameters decline and impaired glucose homeostasis in alloxan diabetic rats. Prague Med Rep 116(2):122–138. https://doi.org/10.14712/23362936.2015.51CrossRefPubMed

27.

Lashner BA et al (2003) Abnormal p53 immunohistochemistry is associated with an increased colorectal cancer-related mortality in patients with ulcerative colitis. Am J Gastroenterol 98(6):1423–1427. https://doi.org/10.1016/S0002-9270(03)00422-2CrossRefPubMed

28.

Li S et al (2005) Crystal structure of a complex between protein tyrosine phosphatase 1B and the insulin receptor tyrosine kinase. Structure 13(11):1643–1651. https://doi.org/10.1016/j.str.2005.07.019CrossRefPubMed

29.

Liu G (2005) protein tyrosine phosphatase 1B inhibition: opportunities and challenges. Curr Med Chem 10(15):1407–1421. https://doi.org/10.2174/0929867033457296CrossRef

30.

Liu H et al (2015) PTP1B promotes cell proliferation and metastasis through activating src and ERK1/2 in non-small cell lung cancer. Cancer Lett 359(2):218–225. https://doi.org/10.1016/j.canlet.2015.01.020CrossRefPubMed

31.

Liu ZQ et al (2015) Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice. Toxicol Appl Pharmacol 285(1):61–70. https://doi.org/10.1016/j.taap.2015.03.011CrossRefPubMed

32.

López I et al (2012) Different mutation profiles associated to P53 accumulation in colorectal cancer. Gene 499(1):81–87. https://doi.org/10.1016/j.gene.2012.02.011CrossRefPubMed

33.

Malik A et al (2011) Role of CD34, vascular endothelial growth factor, and p53 in neoangiogenesis as correlated with stage of disease in colorectal carcinoma. Med J Armed Forces India 67(4):320–325. https://doi.org/10.1016/S0377-1237(11)60076-2CrossRefPubMedPubMedCentral

34.

Melling N et al (2016) High Ki67 expression is an independent good prognostic marker in colorectal cancer. J Clin Pathol 69(3):209–214. https://doi.org/10.1136/jclinpath-2015-202985CrossRefPubMed

35.

Nakamoto K et al (2013) Expression of E-cadherin and KRAS mutation may serve as biomarkers of cetuximab-based therapy in metastatic colorectal cancer. Oncol Lett 5(4):1295–1300. https://doi.org/10.3892/ol.2013.1187CrossRefPubMedPubMedCentral

36.

Nguyen M, Shing Y, Folkman J (1994) Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. Microvasc Res 47:31–40. https://doi.org/10.1006/mvre.1994.1003CrossRefPubMed

37.

Patel MM, Patel BM (2018) Repurposing of sodium valproate in colon cancer associated with diabetes mellitus: role of HDAC inhibition. Eur J Pharm Sci 121:188–199. https://doi.org/10.1016/j.ejps.2018.05.026CrossRefPubMed

38.

Pessin JE, Saltiel AR (2000) On diabetes: insulin resistance Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Investig 106(2):165–169. https://doi.org/10.1172/JCI10582.OnCrossRefPubMedPubMedCentral

39.

Ribatti D (2010) The chick embryo chorioallantoic membrane as an in vivo assay to study antiangiogenesis. Pharmaceuticals 3(3):482–513. https://doi.org/10.3390/ph3030482CrossRefPubMedPubMedCentral

40.

Riccardi C, Nicoletti I (2006) Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 1(3):1458–1461. https://doi.org/10.1038/nprot.2006.238CrossRefPubMed

41.

Salvioli S et al (1997) JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess ΔΨ changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 411(1):77–82. https://doi.org/10.1016/S0014-5793(97)00669-8CrossRefPubMed

42.

Sasaki K et al (2010) Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells. BMC Cancer 10:370. https://doi.org/10.1186/1471-2407-10-370CrossRefPubMedPubMedCentral

43.

Saxena AK et al (1993) Impaired antioxidant status in diabetic rat liver. Effect of vanadate. Biochem Pharmacol 45(3):539–542. https://doi.org/10.1016/0006-2952(93)90124-FCrossRefPubMed

44.

Sen B, Johnson FM (2011) Regulation of Src family kinases in human cancers. J Signal Transduct 2011:1–14. https://doi.org/10.1155/2011/865819CrossRef

45.

Shah NR, Patel BM (2016) Secoisolariciresinol diglucoside rich extract of L. usitatissimum prevents diabetic colon cancer through inhibition of CDK4. Biomed Pharmacother 83:733–739. https://doi.org/10.1016/j.biopha.2016.07.041CrossRefPubMed

46.

Smith IK, Vierheller TL, Thorne CA (1988) Assay of glutathione reductase in crude tissue homogenates using 5,5’-dithiobis(2-nitrobenzoic acid). Anal Biochem 175(2):408–413. https://doi.org/10.1016/0003-2697(88)90564-7CrossRefPubMed

47.

Sun J et al (2015) Magnolia officinalis extract contains potent inhibitors against PTP1B and attenuates hyperglycemia in db/db mice. BioMed Res Int. https://doi.org/10.1155/2015/139451CrossRefPubMedPubMedCentral

48.

Tan Y et al (2006) Ubiquitous calpains promote both apoptosis and survival signals in response to different cell death stimuli. J Biol Chem 281(26):17689–17698. https://doi.org/10.1074/jbc.M601978200CrossRefPubMed

49.

Wright E, Scism-Bacon JL, Glass LC (2006) Oxidative stress in type 2 diabetes: The role of fasting and postprandial glycaemia. Int J Clin Pract 60(3):308–314. https://doi.org/10.1111/j.1368-5031.2006.00825.xCrossRefPubMed

50.

Wu X et al (2001) Depot-specific variation in protein-tyrosine phosphatase activities in human omental and subcutaneous adipose tissue: a potential contribution to differential insulin sensitivity. J Clin Endocrinol Metab 86(12):5973–5980. https://doi.org/10.1210/jcem.86.12.8109CrossRefPubMed

51.

Wu Y et al (2014) Sodium orthovanadate inhibits growth of human hepatocellular carcinoma cells in vitro and in an orthotopic model in vivo. Cancer Lett 351(1):108–116. https://doi.org/10.1016/j.canlet.2014.05.018CrossRefPubMed

52.

Yadav U, Moorthy K, Baquer N (2004) Effects of sodium-orthovanadate and Trigonella foenum-graecum seeds on hepatic and renal lipogenic enzymes and lipid profile during alloxan diabetes. J Biosci 29(1):81–91CrossRefPubMed

53.

Ye J et al (2013) miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal cancer. PLoS ONE 8(4):e60687. https://doi.org/10.1371/journal.pone.0060687CrossRefPubMedPubMedCentral

54.

Yin TF et al (2016) Research progress on chemopreventive effects of phytochemicals on colorectal cancer and their mechanisms. World J Gastroenterol 22(31):7058–7068. https://doi.org/10.3748/wjg.v22.i31.7058CrossRefPubMedPubMedCentral

55.

Zhang Y et al (2017) Protein phosphotyrosine phosphatase 1B (PTP1B) in calpaindependent feedback regulation of vascular endothelial growth factor receptor (VEGFR2) in endothelial cells: implications in VEGF-dependent angiogenesis and diabetic wound healing. J Biol Chem 292(2):407–417. https://doi.org/10.1074/jbc.M116.766832CrossRefPubMed

56.

Zhu S, Bjorge JD, Fujita DJ (2007) PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation. Can Res 67(21):10129–10137. https://doi.org/10.1158/0008-5472.CAN-06-4338CrossRef

57.

Cиpoтa TB (2012) Ключeвыe cлoвa. pp 77–87

Titel: Sodium orthovanadate exhibits anti-angiogenic, antiapoptotic and blood glucose-lowering effect on colon cancer associated with diabetes
verfasst von: Kruti Patel
Vivek Bora
Bhoomika Patel
Publikationsdatum: 27.09.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Cancer Chemotherapy and Pharmacology / Ausgabe 1/2024
Print ISSN: 0344-5704
Elektronische ISSN: 1432-0843
DOI: https://doi.org/10.1007/s00280-023-04596-7

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Sodium orthovanadate exhibits anti-angiogenic, antiapoptotic and blood glucose-lowering effect on colon cancer associated with diabetes

Abstract

Background

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2024

Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells

Bidirectional pharmacokinetic drug interactions between olaparib and metformin

Predictive significance of inflammatory markers and mGPS in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide

Correlation analysis between camrelizumab trough concentration levels and efficacy or safety in East Asian patients with advanced lung cancer

Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?

A phase I study of the ceramide nanoliposome in patients with advanced solid tumors

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie